Using proportions of free to total prostate-specific antigen, age, and total prostate-specific antigen to predict the probability of prostate cancer

Urology

Volumn 47, Issue 4, 1996, Pages 518-524

  Chen, Ya Ting ^a   Luderer, Albert A ^a   Thiel, Robert P ^a   Carlson, Grant ^a   Cuny, Carole L ^a   Soriano, Thomas F ^a  

^a Dianon Systems   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ADULT; AGED; ANTIGEN SPECIFICITY; ARTICLE; CANCER RISK; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE HYPERTROPHY; RADIOIMMUNOASSAY;

EID: 0029933686     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(99)80487-7     Document Type: Article

References (19)

1. Wang MC, Valenzuela LA, Murphy GP, and Chu TM: Purification of a human prostate-specific antigen. Invest Urol 17: 159-163, 1979.
2. Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, and Redwine E: Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 317: 909-916, 1987.
3. Catalona WJ, Smith DS, Ratliff TL, Dodds KM, Coplen DE, Yuan JJ, Petros JA, and Andriole GL: Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 324: 1156-1161, 1991.
4. Partin AW, and Oesterling JE: The clinical usefulness of prostate specific antigen: update 1994. J Urol 152: 1358-1368, 1994.
5. Christensson A, Laurell CB, and Lilja H: Enzymatic activity of prostate-specific antigen and its reactions with extra-cellular serine proteinase inhibitors. Eur J Biochem 194: 755-763, 1990.
6. 1-antichymotrypsin. Clin Chem 37: 1618-1625, 1991.
7. 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res 51: 222-226, 1991.
8. 1-antichymotrypsin as an indicator of prostate cancer. J Urol 150: 100-105, 1993.
9. Leinonen J, Lovgren T, Vornanen T, and Stenman UH: Double-label time-resolved immunofluorometric assay of prostate-specific antigen and of its complex with α1-antichymotrypsin. Clin Chem 39: 2098-2103, 1993.
10. Luderer AA, Chen YT, Soriano TF, Kramp WJ, Carlson G, Cuny C, Sharp T, Smith W, Petteway J, Brawer MK, and Thiel R: Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen. Urology 46: 187-194, 1995.
11. Catalona WJ, Smith DS, Wolfert RL, Tang J, Rittenhouse HG, Ratliff TL, and Nadler RB: Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. JAMA 274: 1214-1220, 1995.
12. Partin AW, Pound CR, Clemens JQ, Epstein JI, and Walsh PC: Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years. Urol Clin North Am 20: 713-725, 1993.
13. Catalona WJ, Richie JP, Ahmann FR, Hudson MA, Scardino PT, Flanigan RC, deKernion JB, Ratliff TL, Kavoussi LR, Dalkin BJ et al: Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol 151: 1283-1290, 1994.
14. Rusciano D, Berardi A, Ceccarini C, and Terrana B: Concomitant purification of prostatic carcinoma tumor markers from human seminal fluid under nondenaturing conditions. Clin Chem 34: 2528-2532, 1988.
15. Gustafson TL: True Epistat, 4th ed. Richardson Tex, Epistat Services, 1991.
16. SPSS Advanced Statistics 6.1: Logit Loglinear Analysis. Chicago, Ill, SPSS, 1994.
17. Keetch DW, Catalona WJ, and Smith DS: Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. J Urol 151: 1571-1574, 1994.
18. Kassabian VS, and Graham SD Jr: Urologie and male genital cancers, in Murphy GP, Lawrence W Jr, and Lenhard RE Jr (Eds). American Cancer Society Textbook of Clinical Oncology, 2nd ed. Atlanta, The American Cancer Society, 1995, pp 317-329.
19. Oesterling JE, Jacobsen SJ, Klee GG, Pettersson K, Piironen P, Abrahamsson PA, Stenman UH, Dowell B, Lougren T, and Lilja H: Free, complexed and total serum prostate specific antigen: the establishment of appropriate reference ranges for their concentrations and ratios. J Urol 154: 1090-1095, 1995.